Table 3.
Baseline features of the participants
| Trials | Age (years) | Males (%) | HbA1c (%) | BMI (kg/m2) |
|---|---|---|---|---|
| 10 mg/25 mg | 10 mg/25 mg | 10 mg/25 mg | 10 mg/25 mg | |
| Araki et al. [7] | 60.8/59.6 | 58.5/72.3 | 7.99/8.06 | 24.6/25.2 |
| Ferrannini et al. [8] | 59.5/59.5 | 48.1/52.7 | 7.89/8.00 | 28.9/28.1 |
| Haring et al. [9] | 55.5/55.6 | 58.0/56.0 | 7.94/7.86 | 29.1/29.7 |
| Kadowak et al. [10] | 57.3/57.9 | 75.7/74.0 | 7.94/7.93 | 25.4/25.4 |
| Roden et al. [11] | 56.2/53.8 | 63.0/65.0 | 7.87/7.86 | 28.3/28.2 |
| Softeland et al. [12] | 54.3/55.4 | 60.6/64.5 | 7.97/7.97 | 31.2/29.9 |
| Takkanen et al. [13] | 60.6/59.9 | 62.0/56.5 | 7.87/7.92 | 32.4/33.0 |
| Zinman et al. [14] | 61.1/61.1 | 73.1/73.9 | 8.06/8.05 | 26.8/26.5 |
HbA1c glycosylated hemoglobin, BMI Body Mass Index